Co-enrollment of critically ill patients into multiple studies : patterns, predictors and consequences
INTRODUCTION: Research on co-enrollment practices and their impact are limited in the ICU setting. The objectives of this study were: 1) to describe patterns and predictors of co-enrollment of patients in a thromboprophylaxis trial, and 2) to examine the consequences of co-enrollment on clinical and trial outcomes.
METHODS: In an observational analysis of an international thromboprophylaxis trial in 67 ICUs, we examined the co-enrollment of critically ill medical-surgical patients into more than one study, and examined the clinical and trial outcomes among co-enrolled and non-co-enrolled patients.
RESULTS: Among 3,746 patients enrolled in PROTECT (Prophylaxis for ThromboEmbolism in Critical Care Trial), 713 (19.0%) were co-enrolled in at least one other study (53.6% in a randomized trial, 37.0% in an observational study and 9.4% in both). Six factors independently associated with co-enrollment (all P < 0.001) were illness severity (odds ratio (OR) 1.35, 95% confidence interval (CI) 1.19 to 1.53 for each 10-point Acute Physiology and Chronic Health Evaluation (APACHE) II score increase), substitute decision-makers providing consent, rather than patients (OR 3.31, 2.03 to 5.41), experience of persons inviting consent (OR 2.67, 1.74 to 4.11 for persons with > 10 years' experience compared to persons with none), center size (all ORs > 10 for ICUs with > 15 beds), affiliation with trials groups (OR 5.59, 3.49 to 8.95), and main trial rather than pilot phase (all ORs > 8 for recruitment year beyond the pilot). Co-enrollment did not influence clinical or trial outcomes or risk of adverse events.
CONCLUSIONS: Co-enrollment was strongly associated with features of the patients, research personnel, setting and study. Co-enrollment had no impact on trial results, and appeared safe, acceptable and feasible. Transparent reporting, scholarly discourse, ethical analysis and further research are needed on the complex topic of co-enrollment during critical illness.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2013 |
---|---|
Erschienen: |
2013 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Critical care (London, England) - 17(2013), 1 vom: 08. Jan., Seite R1 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cook, Deborah [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 17.08.2015 Date Revised 10.11.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/cc11917 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM223999040 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM223999040 | ||
003 | DE-627 | ||
005 | 20231224061943.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/cc11917 |2 doi | |
028 | 5 | 2 | |a pubmed24n0746.xml |
035 | |a (DE-627)NLM223999040 | ||
035 | |a (NLM)23298553 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cook, Deborah |e verfasserin |4 aut | |
245 | 1 | 0 | |a Co-enrollment of critically ill patients into multiple studies |b patterns, predictors and consequences |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.08.2015 | ||
500 | |a Date Revised 10.11.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: Research on co-enrollment practices and their impact are limited in the ICU setting. The objectives of this study were: 1) to describe patterns and predictors of co-enrollment of patients in a thromboprophylaxis trial, and 2) to examine the consequences of co-enrollment on clinical and trial outcomes | ||
520 | |a METHODS: In an observational analysis of an international thromboprophylaxis trial in 67 ICUs, we examined the co-enrollment of critically ill medical-surgical patients into more than one study, and examined the clinical and trial outcomes among co-enrolled and non-co-enrolled patients | ||
520 | |a RESULTS: Among 3,746 patients enrolled in PROTECT (Prophylaxis for ThromboEmbolism in Critical Care Trial), 713 (19.0%) were co-enrolled in at least one other study (53.6% in a randomized trial, 37.0% in an observational study and 9.4% in both). Six factors independently associated with co-enrollment (all P < 0.001) were illness severity (odds ratio (OR) 1.35, 95% confidence interval (CI) 1.19 to 1.53 for each 10-point Acute Physiology and Chronic Health Evaluation (APACHE) II score increase), substitute decision-makers providing consent, rather than patients (OR 3.31, 2.03 to 5.41), experience of persons inviting consent (OR 2.67, 1.74 to 4.11 for persons with > 10 years' experience compared to persons with none), center size (all ORs > 10 for ICUs with > 15 beds), affiliation with trials groups (OR 5.59, 3.49 to 8.95), and main trial rather than pilot phase (all ORs > 8 for recruitment year beyond the pilot). Co-enrollment did not influence clinical or trial outcomes or risk of adverse events | ||
520 | |a CONCLUSIONS: Co-enrollment was strongly associated with features of the patients, research personnel, setting and study. Co-enrollment had no impact on trial results, and appeared safe, acceptable and feasible. Transparent reporting, scholarly discourse, ethical analysis and further research are needed on the complex topic of co-enrollment during critical illness | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Observational Study | |
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
700 | 1 | |a McDonald, Ellen |e verfasserin |4 aut | |
700 | 1 | |a Smith, Orla |e verfasserin |4 aut | |
700 | 1 | |a Zytaruk, Nicole |e verfasserin |4 aut | |
700 | 1 | |a Heels-Ansdell, Diane |e verfasserin |4 aut | |
700 | 1 | |a Watpool, Irene |e verfasserin |4 aut | |
700 | 1 | |a McArdle, Tracy |e verfasserin |4 aut | |
700 | 1 | |a Matte, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Clarke, France |e verfasserin |4 aut | |
700 | 1 | |a Vallance, Shirley |e verfasserin |4 aut | |
700 | 1 | |a Finfer, Simon |e verfasserin |4 aut | |
700 | 1 | |a Galt, Pauline |e verfasserin |4 aut | |
700 | 1 | |a Crozier, Tim |e verfasserin |4 aut | |
700 | 1 | |a Fowler, Rob |e verfasserin |4 aut | |
700 | 1 | |a Arabi, Yaseen |e verfasserin |4 aut | |
700 | 1 | |a Woolfe, Clive |e verfasserin |4 aut | |
700 | 1 | |a Orford, Neil |e verfasserin |4 aut | |
700 | 1 | |a Hall, Richard |e verfasserin |4 aut | |
700 | 1 | |a Adhikari, Neill K J |e verfasserin |4 aut | |
700 | 1 | |a Ferland, Marie-Clauide |e verfasserin |4 aut | |
700 | 1 | |a Marshall, John |e verfasserin |4 aut | |
700 | 1 | |a Meade, Maureen |e verfasserin |4 aut | |
700 | 0 | |a PROTECT Research Coordinators |e verfasserin |4 aut | |
700 | 0 | |a PROTECT Investigators |e verfasserin |4 aut | |
700 | 0 | |a Canadian Critical Care Trials Group |e verfasserin |4 aut | |
700 | 0 | |a Australian and New Zealand Intensive Care Society Clinical Trials Group |e verfasserin |4 aut | |
700 | 1 | |a Cook, Deborah |e investigator |4 oth | |
700 | 1 | |a McDonald, Ellen |e investigator |4 oth | |
700 | 1 | |a Tkaczyk, Andrea |e investigator |4 oth | |
700 | 1 | |a Clarke, France |e investigator |4 oth | |
700 | 1 | |a Wallace, Christine |e investigator |4 oth | |
700 | 1 | |a Hall, Rick |e investigator |4 oth | |
700 | 1 | |a Rocker, Graeme |e investigator |4 oth | |
700 | 1 | |a Julien, Lisa |e investigator |4 oth | |
700 | 1 | |a Wright, Debbie |e investigator |4 oth | |
700 | 1 | |a Roy, Caroline |e investigator |4 oth | |
700 | 1 | |a Theriault, Judy |e investigator |4 oth | |
700 | 1 | |a Pleasance, Susan |e investigator |4 oth | |
700 | 1 | |a Snow, Debi |e investigator |4 oth | |
700 | 1 | |a Herbert, Shannon |e investigator |4 oth | |
700 | 1 | |a Meade, Maureen |e investigator |4 oth | |
700 | 1 | |a Hand, Lori |e investigator |4 oth | |
700 | 1 | |a Biljan, Maya |e investigator |4 oth | |
700 | 1 | |a Freitag, Andreas |e investigator |4 oth | |
700 | 1 | |a Wynne, Christine |e investigator |4 oth | |
700 | 1 | |a Duffett, Mark |e investigator |4 oth | |
700 | 1 | |a Kho, Michelle |e investigator |4 oth | |
700 | 1 | |a Zytaruk, Nicole |e investigator |4 oth | |
700 | 1 | |a Currie, Karen |e investigator |4 oth | |
700 | 1 | |a Granton, John |e investigator |4 oth | |
700 | 1 | |a Matte, Andrea |e investigator |4 oth | |
700 | 1 | |a Farias, Paulina |e investigator |4 oth | |
700 | 1 | |a Chu, Leslie |e investigator |4 oth | |
700 | 1 | |a Brockest, Nancy |e investigator |4 oth | |
700 | 1 | |a Go, Stephanie |e investigator |4 oth | |
700 | 1 | |a McGrath-Chong, Margaret |e investigator |4 oth | |
700 | 1 | |a Dennis, Madison |e investigator |4 oth | |
700 | 1 | |a Lipkus, Marc |e investigator |4 oth | |
700 | 1 | |a Stern, Emily |e investigator |4 oth | |
700 | 1 | |a Albert, Ryan |e investigator |4 oth | |
700 | 1 | |a Seto, Ron |e investigator |4 oth | |
700 | 1 | |a Zuberi, Muhammad |e investigator |4 oth | |
700 | 1 | |a Ming, Jie |e investigator |4 oth | |
700 | 1 | |a Arus-Pampin, Laura |e investigator |4 oth | |
700 | 1 | |a Walid, Muhammad |e investigator |4 oth | |
700 | 1 | |a Solek, Robert |e investigator |4 oth | |
700 | 1 | |a De freitas, Kim |e investigator |4 oth | |
700 | 1 | |a Langevin, Stephan |e investigator |4 oth | |
700 | 1 | |a Lauzier, François |e investigator |4 oth | |
700 | 1 | |a Turgeon, Alexis F |e investigator |4 oth | |
700 | 1 | |a Blais, Martine |e investigator |4 oth | |
700 | 1 | |a Beauparlant, Maxime |e investigator |4 oth | |
700 | 1 | |a Asselin, Julie |e investigator |4 oth | |
700 | 1 | |a Roy, Caroline |e investigator |4 oth | |
700 | 1 | |a Gagné, Chantal |e investigator |4 oth | |
700 | 1 | |a Thibodeau, Marie |e investigator |4 oth | |
700 | 1 | |a Rioux, Anik |e investigator |4 oth | |
700 | 1 | |a Tran, Tuong-Vi |e investigator |4 oth | |
700 | 1 | |a Poirier, Germain |e investigator |4 oth | |
700 | 1 | |a Neas, Isabelle |e investigator |4 oth | |
700 | 1 | |a Spearson, Sandrine |e investigator |4 oth | |
700 | 1 | |a Ton, Betty |e investigator |4 oth | |
700 | 1 | |a McIntyre, Lauralyn |e investigator |4 oth | |
700 | 1 | |a Hébert, Paul |e investigator |4 oth | |
700 | 1 | |a Watpool, Irene |e investigator |4 oth | |
700 | 1 | |a McArdle, Tracy |e investigator |4 oth | |
700 | 1 | |a Gaudert, Claude |e investigator |4 oth | |
700 | 1 | |a Marchand, Paule |e investigator |4 oth | |
700 | 1 | |a Davidson, Carson |e investigator |4 oth | |
700 | 1 | |a Dugal, Anne-Marie |e investigator |4 oth | |
700 | 1 | |a Fetzer, Susan |e investigator |4 oth | |
700 | 1 | |a Pagliarello, Joe |e investigator |4 oth | |
700 | 1 | |a Lewis, Mary-Jo |e investigator |4 oth | |
700 | 1 | |a Murphy, Erin |e investigator |4 oth | |
700 | 1 | |a Foxall, Julia |e investigator |4 oth | |
700 | 1 | |a Weir, Sherry |e investigator |4 oth | |
700 | 1 | |a Skrobik, Yoanna |e investigator |4 oth | |
700 | 1 | |a Harvey, Johanne |e investigator |4 oth | |
700 | 1 | |a Chitu, Stefania |e investigator |4 oth | |
700 | 1 | |a Quach, Marceline |e investigator |4 oth | |
700 | 1 | |a Pinet, Linda |e investigator |4 oth | |
700 | 1 | |a Albert, Martin |e investigator |4 oth | |
700 | 1 | |a Sirois, Carole |e investigator |4 oth | |
700 | 1 | |a Nadon, Carole |e investigator |4 oth | |
700 | 1 | |a Dolle, Stéphanie |e investigator |4 oth | |
700 | 1 | |a Gosselin, Audrey-Anne |e investigator |4 oth | |
700 | 1 | |a Deroy, Patrice |e investigator |4 oth | |
700 | 1 | |a Frenette, Anne Julie |e investigator |4 oth | |
700 | 1 | |a Williamson, David |e investigator |4 oth | |
700 | 1 | |a Mehta, Sangeeta |e investigator |4 oth | |
700 | 1 | |a Ethier, Cheryl |e investigator |4 oth | |
700 | 1 | |a Tirgari, Sam |e investigator |4 oth | |
700 | 1 | |a Steinberg, Lindsay |e investigator |4 oth | |
700 | 1 | |a McDonald, Rod |e investigator |4 oth | |
700 | 1 | |a Sivanantham, Vidhya |e investigator |4 oth | |
700 | 1 | |a Bandayrel, Kristofer |e investigator |4 oth | |
700 | 1 | |a Pelletier, Friederike Quittnat |e investigator |4 oth | |
700 | 1 | |a Kramer-Kile, Marnie |e investigator |4 oth | |
700 | 1 | |a Brown, Maedean |e investigator |4 oth | |
700 | 1 | |a Kim, Scott |e investigator |4 oth | |
700 | 1 | |a Leung, Holly |e investigator |4 oth | |
700 | 1 | |a Fowler, Robert |e investigator |4 oth | |
700 | 1 | |a Marinoff, Nicole |e investigator |4 oth | |
700 | 1 | |a Code, Karen |e investigator |4 oth | |
700 | 1 | |a Bojilov, Boris |e investigator |4 oth | |
700 | 1 | |a Parsotam, Derek |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Critical care (London, England) |d 1997 |g 17(2013), 1 vom: 08. Jan., Seite R1 |w (DE-627)NLM097399787 |x 1466-609X |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2013 |g number:1 |g day:08 |g month:01 |g pages:R1 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/cc11917 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2013 |e 1 |b 08 |c 01 |h R1 |